Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Temsirolimus and Irinotecan in Chemotherapy Refractory Patients With KRAS Mutated Metastatic Colorectal Cancer

NCT00827684 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT00827684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00827684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Temsirolimus and Irinotecan in Chemotherapy Refractory Patients With KRAS Mutated Metastatic Colorectal Cancer
Lead sponsor
Vejle Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
June 30, 2011
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer